Cargando…
Molecular Recognition of Gangliosides and Their Potential for Cancer Immunotherapies
Gangliosides are sialic-acid-containing glycosphingolipids expressed on all vertebrate cells. They are primarily positioned in the plasma membrane with the ceramide part anchored in the membrane and the glycan part exposed on the surface of the cell. These lipids have highly diverse structures, not...
Autores principales: | Krengel, Ute, Bousquet, Paula A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104838/ https://www.ncbi.nlm.nih.gov/pubmed/25101077 http://dx.doi.org/10.3389/fimmu.2014.00325 |
Ejemplares similares
-
SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7
por: Bousquet, Paula A., et al.
Publicado: (2022) -
Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry
por: Vázquez, Ana M. H., et al.
Publicado: (2012) -
O-acetylated Gangliosides as Targets for Cancer Immunotherapy
por: Cavdarli, Sumeyye, et al.
Publicado: (2020) -
The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
por: D’souza, Nishelle, et al.
Publicado: (2021) -
Biology of GD2 ganglioside: implications for cancer immunotherapy
por: Machy, Pierre, et al.
Publicado: (2023)